These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 18837837)

  • 21. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
    Chen H; Cantrell CR
    Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
    Sartori AM; de Soárez PC; Novaes HM; Amaku M; de Azevedo RS; Moreira RC; Pereira LM; Ximenes RA; Martelli CM
    Vaccine; 2012 Dec; 30(52):7489-97. PubMed ID: 23107593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis A outbreaks: the effect of a mass vaccination programme.
    Torner N; Broner S; Martinez A; Godoy P; Batalla J; Dominguez A;
    J Viral Hepat; 2011 Apr; 18(4):e1-4. PubMed ID: 21129127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis A in the era of vaccination.
    Wasley A; Fiore A; Bell BP
    Epidemiol Rev; 2006; 28():101-11. PubMed ID: 16775039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Universal hepatitis A vaccination in the United States: a call for action.
    Lieberman JM; Word BM; Jacobs RJ; Dagan R; Marchant CD
    Pediatr Infect Dis J; 2008 Apr; 27(4):287-91. PubMed ID: 18316993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A statistical model to estimate the impact of a hepatitis A vaccination programme.
    Oviedo M; Pilar Muñoz M; Domínguez A; Borras E; Carmona G
    Vaccine; 2008 Nov; 26(48):6157-64. PubMed ID: 18804511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of hepatitis A by universal vaccination of children and adolescents: an achieved goal or a deferred appointment?
    Martinelli D; Bitetto I; Tafuri S; Lopalco PL; Mininni RM; Prato R
    Vaccine; 2010 Sep; 28(41):6783-8. PubMed ID: 20688041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.
    Rein DB; Hicks KA; Wirth KE; Billah K; Finelli L; Fiore AE; Hoerger TJ; Bell BP; Armstrong GL
    Pediatrics; 2007 Jan; 119(1):e12-21. PubMed ID: 17200237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.
    Suijkerbuijk AW; Lugnér AK; van Pelt W; Wallinga J; Verhoef LP; de Melker HE; de Wit GA
    Vaccine; 2012 Jul; 30(35):5199-205. PubMed ID: 22721900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vaccination against hepatitis A in children].
    Gendrel D
    Arch Pediatr; 2004 Nov; 11(11):1360-6. PubMed ID: 15519837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis A vaccine recommendations.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):189-99. PubMed ID: 17606579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of hepatitis A in the United States in the era of vaccination.
    Wasley A; Samandari T; Bell BP
    JAMA; 2005 Jul; 294(2):194-201. PubMed ID: 16014593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-benefit analysis of hepatitis a vaccination in Thailand.
    Teppakdee A; Tangwitoon A; Khemasuwan D; Tangdhanakanond K; Suramaethakul N; Sriratanaban J; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):118-27. PubMed ID: 12118439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The changing epidemiology of hepatitis A in Arizona following intensive immunization programs (1988-2007).
    Erhart LM; Ernst KC
    Vaccine; 2012 Sep; 30(42):6103-10. PubMed ID: 22835739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of Hepatitis A Twelve Years After the Implementation of Toddlers' Vaccination: A Population-Based Study in Israel.
    Bassal R; Weil M; Cohen D; Sofer D; Mendelson E; Shohat T
    Pediatr Infect Dis J; 2017 Oct; 36(10):e248-e251. PubMed ID: 28498301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004).
    Sonder GJ; Bovée LP; Baayen TD; Coutinho RA; van den Hoek JA
    Vaccine; 2006 Jun; 24(23):4962-8. PubMed ID: 16675076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
    Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
    Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program.
    Zhuang FC; Qian W; Mao ZA; Gong YP; Jiang Q; Jiang LM; Chen NL; Chai SA; Mao JS
    Chin Med J (Engl); 2005 Nov; 118(22):1851-6. PubMed ID: 16313838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiologic shift in the prevalence of Hepatitis A virus in Saudi Arabia: a case for routine Hepatitis A vaccination.
    Almuneef MA; Memish ZA; Balkhy HH; Qahtani M; Alotaibi B; Hajeer A; Qasim L; Al Knawy B
    Vaccine; 2006 Jul; 24(27-28):5599-603. PubMed ID: 16757065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.